Perbedaan Kadar Endotelin-1 pada Penderita Hipertensi Stadium 1, 2 dan Bukan Penderita Hipertensi

Agus Widyatmoko

Abstract


Hypertension is a risk factor of cardiovascular disease. Endothelin-1 is a strong vasoconstrictor andrelatedwith angiotensin IIin the arteriapressure regulation. This regulation influence in pathologic condition such as hypertension, congestive heart failure and cronic renal failure. The aim of this study is to compare the levels of endothelin-1 between the patient of hypertension stage 1; stage 2 and no hypertension person. The design of this study is cross sectional. Subjects were resident in the territory of District Health Center 2 Mlati, Sleman, DIY, men and women, aged 18-75 years. Hypertension Stage 1, Stage 2 and no hypertension groups were determined according to Joint National Committee (JNC) 7 criteria. Research subjects used randomly with stratification, fasting at least 8 hours before blood samples were taken for examination to measure the level of endothelin-1. There are 43 patients with hypertension stage 1, 54 patients with hypertension stage 2 and 54 non hypertension person. The difference of endothelin-1 level among groups were analyzed by Anova. This research shows that the increasing levels of endothelin-1 is in a row with increasing of blood pressure in hypertension stage 1 and 2; and the increasing more clear and meaningful in the 50-75 year age of group.

Hipertensi merupakan faktor risiko penyakit jantung. Endotelin-1 adalah vasokonstriktor kuat dan berkaitan dengan angiotensin II dalam pengaturan tekanan arteria. Pengaturan ini berpengaruh terhadap kondisi patologis seperti hipertensi, gagal jantung kongesti dan gagal ginjal kronis. Tujuan penelitian ini adalah ingin membandingkan kadar endotelin-1 antara penderita hipertensi stadium 1; stadium 2, dan bukan penderita hipertensi. Rancangan penelitian ini adalah cross sectional. Subjek adalah penduduk di wilayah Kabupaten Puskesmas 2 Mlati, Sleman, DIY, pria dan wanita, usia 18-75 tahun. Hipertensi stadium 1, stadium 2 dan bukan penderita hipertensi ditentukan menurut kriteria JNC 7. Subyek penelitian diambil secara acak dengan stratifikasi, puasa minimal 8 jam sebelum sampel darah diambil untuk pemeriksaan kadar endotelin-1. Ada 43 pasien dengan hipertensi stadium 1, 54 pasien dengan hipertensi stadium 2 dan 54 orang non hipertensi. Perbedaan kadar endotelin-1 antar kelompok dianalisis dengan Anova. Hasil penelitian ini menunjukkan bahwa semakin tinggi kadar endotelin-1 maka semakin meningkat tekanan darah pada hipertensi tahap 1 dan 2; dan peningkatan usia lebih jelas dan berarti pada kelompok usia 50-75 tahun.


Keywords


endotelin-1; hipertensi; kriteria Joint National Committee (JNC) 7; endothelin-1; hypertension; Joint National Committee (JNC) 7 criteria

Full Text:

PDF

References


Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr., et al. 2003. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 42:1206 -1252.

Kearney, P.M. , Whelton, M. and Reynolds, K. 2004. Worldwide prevalence of hypertension: a systematic review. J Hypertens: 22: 11 - 9

Fields, L.E., Burt, V.L., and Cutler, J.A. 2004. The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension: 44: 398 - 404

Departemen Kesehatan RI. 2006. Profil kesehatan Indonesia tahun 2006. Depkes RI. 45 - 47.

Oparil, S., Zaman, A.M., and Calhoun, D.A. 2003. Pathogenesis of Hypertension. Ann Intern Med. 139:761-76

Levin, E.R. 1995. Endothelins. N. Engl. J .Med. Vol. 333 No. 6: 356 - 363

Reckelhoff, J.F. and Romero, J.C. 2003. Role of oxidative stress in angiotensin- induced hypertension. Am. J .Physiol. Regul. Integr. Comp Physiol. 284: R893-R912

Ballew, J.R. and Fink, G.D. 2001. Role of ETA receptors in experimental ANG II-induced hypertension in rats. Am J Physiol Regul Integr Comp Physiol 281: R150-R154

Alexander, B.T.; Cockrell K.L.; Rinewalt A.N.; Herrington J.N.; and Granger J.P.

Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension. Am. J. Physiol. Regul. Integr .Comp. Physiol. 280: R1388-R1392, 2001.

Van Guilder, GP., Westby, CM., Greiner, JJ., Stauffer, BL., DeSouza, CA. 2007. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension. 50:403

Schiffrin, E. L. 1999. Role of endothelin-1 in hypertension. Hypertension 34(2), 876-881.

Letizia, C., Cerci, S., DeToma, G., D’Ambrosio, C., De Ciochis, A., Coassins, et al. 1997. High plasma endothelin-1 levels in hypertensive patients with low rennin essential hypertension. J. Hum. Hypertens. 11(7):447-451

Taddei, S., Virdis, A., Ghiadoni, L., Sudano, I., Notari, M., Salvetti, A. 1999. Vasoconstriction to endogenous endothelial is increased in the peripheral circulation patients with essential hypertension. Circulation. 100:1680¬1683.

Cardillo, C., Campia, U., Kilcoyne, C. M., Bryant, M. B., and Panza, J. A. 2002. Improved endotheliumdependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 105, 452¬456.




DOI: https://doi.org/10.18196/mmjkk.v10i2.1570

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


      

Editorial Office:
Journal Room, G1 (Biomedic) Building, Ground Floor, Faculty of Medicine and Health Science Universitas Muhammadiyah Yogyakarta, 
Jalan Lingkar Selatan (Brawijaya), Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta, Indonesia
Phone: +62 274 387 656 (ext: 231)
WA : +62 811-2650-303
Website: http://journal.umy.ac.id/index.php/mm 
E-mail: mmjkk@umy.university

Creative Commons License
Mutiara Medika: Jurnal Kedokteran dan Kesehatan is licensed under a Creative Commons Attribution 4.0 International License. View My Stats